SP628ETELCALCETIDE, A NEW INTRAVENOUS CALCIMIMETIC DRUG IN THE MANAGEMENT OF SECONDARY HYPERPARATIROIDISM IN HEMODIALISIS PATIENTS. RESULTS IN OUR CENTRE | Zendy

AI Assistant Blog Pricing

SP628ETELCALCETIDE, A NEW INTRAVENOUS CALCIMIMETIC DRUG IN THE MANAGEMENT OF SECONDARY HYPERPARATIROIDISM IN HEMODIALISIS PATIENTS. RESULTS IN OUR CENTRE

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.